Suppr超能文献

杀伤性 B 淋巴细胞:证据与潜能

Killer B lymphocytes: the evidence and the potential.

机构信息

Division of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-2200, USA.

出版信息

Inflamm Res. 2009 Jul;58(7):345-57. doi: 10.1007/s00011-009-0014-x. Epub 2009 Mar 5.

Abstract

Immune regulation plays a critical role in controlling potentially dangerous inflammation and maintaining health. The Fas ligand/Fas receptor axis has been studied extensively as a mechanism of killing T cells and other cells during infections, autoimmunity, and cancer. FasL expression has been primarily attributed to activated T cells and NK cells. Evidence has emerged that B lymphocytes can express FasL and other death-inducing ligands, and can mediate cell death under many circumstances. Among B cell subsets, the expression of both Fas ligand and IL-10 is highest on the CD5(+) B cell population, suggesting that CD5(+) B cells may have a specialized regulatory function. The relevance of killer B cells to normal immune regulation, disease pathogenesis, and inflammation is discussed.

摘要

免疫调节在控制潜在危险的炎症和维持健康方面起着关键作用。Fas 配体/Fas 受体轴已被广泛研究作为感染、自身免疫和癌症期间杀死 T 细胞和其他细胞的机制。FasL 的表达主要归因于活化的 T 细胞和 NK 细胞。有证据表明 B 淋巴细胞可以表达 FasL 和其他诱导细胞死亡的配体,并在许多情况下介导细胞死亡。在 B 细胞亚群中,CD5+B 细胞群上 Fas 配体和 IL-10 的表达最高,表明 CD5+B 细胞可能具有特殊的调节功能。讨论了杀伤 B 细胞与正常免疫调节、疾病发病机制和炎症的相关性。

相似文献

1
Killer B lymphocytes: the evidence and the potential.
Inflamm Res. 2009 Jul;58(7):345-57. doi: 10.1007/s00011-009-0014-x. Epub 2009 Mar 5.
2
Characterization and activity of Fas ligand producing CD5⁺ B cells.
Methods Mol Biol. 2014;1190:81-102. doi: 10.1007/978-1-4939-1161-5_7.
3
Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes.
Methods Mol Biol. 2021;2270:149-178. doi: 10.1007/978-1-0716-1237-8_9.
4
Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.
Arthritis Res Ther. 2009;11(4):R128. doi: 10.1186/ar2795. Epub 2009 Aug 25.
7
Multiple mechanisms of immune suppression by B lymphocytes.
Mol Med. 2012 Feb 10;18(1):123-37. doi: 10.2119/molmed.2011.00333.
8
Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.
Int Rev Immunol. 1999;18(5-6):485-513. doi: 10.3109/08830189909088495.
9
B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
J Leukoc Biol. 2005 Nov;78(5):1052-9. doi: 10.1189/jlb.0904536. Epub 2005 Oct 4.

引用本文的文献

1
B cells in tumor metastasis: friend or foe?
Int J Biol Sci. 2023 Apr 29;19(8):2382-2393. doi: 10.7150/ijbs.79482. eCollection 2023.
2
The emerging role of regulatory cell-based therapy in autoimmune disease.
Front Immunol. 2022 Dec 14;13:1075813. doi: 10.3389/fimmu.2022.1075813. eCollection 2022.
3
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.
Nat Rev Cancer. 2022 Jul;22(7):414-430. doi: 10.1038/s41568-022-00466-1. Epub 2022 Apr 7.
5
The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis.
Biomedicines. 2022 Mar 4;10(3):606. doi: 10.3390/biomedicines10030606.
6
Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer.
Front Immunol. 2021 Nov 19;12:747780. doi: 10.3389/fimmu.2021.747780. eCollection 2021.
7
A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis.
Front Immunol. 2021 May 14;12:676046. doi: 10.3389/fimmu.2021.676046. eCollection 2021.
8
Advances of Regulatory B Cells in Autoimmune Diseases.
Front Immunol. 2021 Apr 15;12:592914. doi: 10.3389/fimmu.2021.592914. eCollection 2021.
10
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.
Front Immunol. 2021 Feb 18;12:640168. doi: 10.3389/fimmu.2021.640168. eCollection 2021.

本文引用的文献

1
Regulatory role of B cells in a murine model of allergic airway disease.
J Immunol. 2008 Jun 1;180(11):7318-26. doi: 10.4049/jimmunol.180.11.7318.
3
Not always the bad guys: B cells as regulators of autoimmune pathology.
Nat Rev Immunol. 2008 May;8(5):391-7. doi: 10.1038/nri2315.
4
B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation.
Cancer Lett. 2008 Aug 8;266(2):227-37. doi: 10.1016/j.canlet.2008.02.067. Epub 2008 Apr 15.
5
TLR-activated B cells suppress T cell-mediated autoimmunity.
J Immunol. 2008 Apr 1;180(7):4763-73. doi: 10.4049/jimmunol.180.7.4763.
7
The 'short' history of regulatory B cells.
Trends Immunol. 2008 Jan;29(1):34-40. doi: 10.1016/j.it.2007.10.004. Epub 2007 Dec 3.
8
B-cell depletion and repopulation in autoimmune diseases.
Clin Rev Allergy Immunol. 2008 Feb;34(1):50-5. doi: 10.1007/s12016-007-8015-4.
10
Depletion of B cells in murine lupus: efficacy and resistance.
J Immunol. 2007 Sep 1;179(5):3351-61. doi: 10.4049/jimmunol.179.5.3351.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验